MedTrace Logo

A Study to Learn How Different Forms of Study Medicine Tafamidis Are Taken Up Into The Blood in Healthy Adults

NCT06273839 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2024-06-26

No results posted yet for this study

Summary

The purpose of this clinical trial is to compare the amount of tafamidis in the blood of healthy adult participants after taking three different forms of tafamidis by mouth.

Conditions

  • Healthy

Interventions

DRUG

Tafamidis 61 mg free acid tablet (Test 1)

Tafamidis 61 mg free acid tablet (Test 1)

DRUG

Tafamidis 70 mg free acid tablet (Test 1)

Tafamidis 61 mg free acid tablet (Test 1)

DRUG

Tafamidis 61 mg free acid capsule (Reference)

Tafamidis 61 mg free acid capsule (Reference)

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-02-27
Primary Completion
2024-05-27
Completion
2024-05-27
FDA Drug
Yes

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06273839 on ClinicalTrials.gov